MADRIGAL PHARMACEUTICALS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $958.4 | $180.1 | $0.0 | $0.0 | $0.0 |
| Operating income | -$300.1 | -$497.9 | -$380.5 | -$293.6 | -$242.5 |
| Net income | -$288.3 | -$465.9 | -$373.6 | -$295.4 | -$241.8 |
| Balance Sheet | |||||
| Total debt | $485.8 | $143.5 | $145.8 | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$190.0 | -$457.0 | -$325.7 | -$225.1 | -$184.1 |
Shares outstanding 23.1M · Free float 81.8%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.